NIH updates regulations on conflict of interest
On 3 February, in response to Congressional inquiries and public hearings in the House and Senate about consulting activities of several NIH employees, the National Institutes of Health (NIH) published an interim role with request for comments relating to outside activities, financial holdings, and awards for all NIH employees1.
According to a recent press release from the agency, “All NIH employees are prohibited from engaging in certain outside employment with:
“1) Substantially affected organizations, including pharmaceutical and biotechnology companies;
“2) Supported research institutions, including NIH grantees;
“3) Health care providers and insurers; and
“4) Related trade, professional or similar associations2.”
NIH employees may not invest in organizations substantially affected by the NIH (e.g., biotechnology and pharmaceutical industries), and are required to file public and confidential financial disclosure reports. However, according to the NIH, they may continue “teaching courses at universities, writing general textbooks, performing scientific journal reviews, participating in scientific meetings and providing general lectures to physicians and scientists at continuing professional education and similar events, as well as practicing medicine as appropriate, provided that the activities are otherwise in accordance with existing law and adhere strictly to the conditions specified in the new rules2.”
References
DHHS. Interim final rule with request for comments. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Federal Register 70(22), 5543–5565 (3 February 2005).
NIH. NIH announces sweeping ethics reform. (1 February 2005). http://www.nih.gov/news/pr/feb2005/od-01.htm.
Rights and permissions
About this article
Cite this article
Shalev, M. Regulation update. Lab Anim 34, 18 (2005). https://doi.org/10.1038/laban0405-18b
Issue Date:
DOI: https://doi.org/10.1038/laban0405-18b